Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

IBRXIBRX
Showing 8 of 22 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in IMMUNITYBIO INC

GEODE CAPITAL MANAGEMENT, LLC holds 9.8M shares of IBRX (IMMUNITYBIO INC), worth $86.2M as of 2026-Q2. The position was increased (+22.6% shares). IBRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$86.2M

Current Shares

9.8M

Total Value Change

+$71.9M

Total Shares Change

+6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.8M
+22.6%
$86.2M0.0%$8.76
36
2026-Q1
Increased
8M
+1.4%
$61.6M0.0%$7.67
30
2025-Q4
Increased
7.9M
+14.9%
$15.7M0.0%$1.98
32
2025-Q3
Increased
6.9M
+19.3%
$17M0.0%$2.46
33
2025-Q2
Increased
5.8M
+34.7%
$15.3M0.0%$2.64
36
2025-Q1
Increased
4.3M
+11.7%
$12.9M0.0%$3.01
31
2024-Q4
Decreased
3.8M
-0.1%
$9.8M0.0%$2.56
0
2024-Q3
Decreased
3.8M
-1.8%
$14.3M0.0%$3.72
0

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used